WMSA
ABBV icon

Weiss Multi-Strategy Advisers’s AbbVie ABBV Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,723
Closed -$577K – 5
2023
Q4 		$577K Sell
3,723
-23,443
-86% -$3.42M 0.01% 472
2023
Q3 		$4.05M Buy
+27,166
New +$3.99M 0.1% 268
2023
Q2 		– Sell
-57,266
Closed -$9.13M – 621
2023
Q1 		$9.13M Sell
57,266
-26,564
-32% -$4.06M 0.21% 142
2022
Q4 		$13.5M Sell
83,830
-5,752
-6% -$882K 0.38% 73
2022
Q3 		$12M Buy
89,582
+38,935
+77% +$5.59M 0.32% 98
2022
Q2 		$7.76M Buy
50,647
+13,993
+38% +$2.14M 0.23% 152
2022
Q1 		$5.94M Buy
36,654
+5,719
+18% +$831K 0.14% 236
2021
Q4 		$4.19M Sell
30,935
-130
-0.4% -$15.4K 0.09% 273
2021
Q3 		$3.35M Buy
31,065
+5,055
+19% +$578K 0.07% 324
2021
Q2 		$2.93M Sell
26,010
-4,062
-14% -$457K 0.06% 355
2021
Q1 		$3.25M Sell
30,072
-581
-2% -$62.1K 0.07% 335
2020
Q4 		$3.28M Buy
+30,653
New +$2.95M 0.06% 333
2020
Q3 		– Sell
-5,270
Closed -$517K – 546
2020
Q2 		$517K Buy
+5,270
New +$464K 0.01% 464
2019
Q4 		– Sell
-11,593
Closed -$878K – 579
2019
Q3 		$878K Sell
11,593
-13,407
-54% -$919K 0.02% 456
2019
Q2 		$1.82M Buy
25,000
+20,000
+400% +$1.57M 0.05% 316
2019
Q1 		$403K Buy
+5,000
New +$409K 0.01% 450
2014
Q2 		– Sell
-26,410
Closed -$1.36M – 708
2014
Q1 		$1.36M Buy
26,410
+11,410
+76% +$577K 0.03% 420
2013
Q4 		$792K Buy
+15,000
New +$737K 0.02% 489

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Weiss Multi-Strategy Advisers's ABBV Position: Q1 2024 in Review

Weiss Multi-Strategy Advisers sold out of AbbVie (ABBV) in Q1 2024, closing a stake of 3,723 shares — an estimated $577K sold.

Weiss Multi-Strategy Advisers first reported a position in ABBV in Q4 2013 and held it in 18 quarters. The position peaked at $13.5M in Q4 2022. 3,379 funds tracked by Wall St. Rank hold ABBV as of Q1 2024.

  • Weiss Multi-Strategy Advisers reported no remaining AbbVie position as of Q1 2024 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 3,723 AbbVie shares in Q1 2024, an estimated $577K.
  • Weiss Multi-Strategy Advisers first reported a position in AbbVie in Q4 2013 and held it in 18 quarters.
  • Weiss Multi-Strategy Advisers's AbbVie position peaked at $13.5M in Q4 2022.
  • 3,379 funds tracked by Wall St. Rank held AbbVie as of Q1 2024.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.